UNSPSC 51332800: Antipsychotic phenothiazines

Antipsychotic drugs made from Compounds containing dibenzo-1,4-thiazine.

UNSPSC 51332800 Antipsychotic phenothiazines is a Class code that nominally covers antipsychotic medications in the phenothiazine class, but recent state and local procurement activity under this code shows substantial mismatch — the code is being applied to broader pharmaceutical procurement including naloxone, generic multi-source drugs, and OTC products rather than to antipsychotic phenothiazines specifically. State and local issuing bodies applying this code include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. The scope of work being solicited ranges from direct purchase of emergency-response medications (naloxone) and drug deactivation systems to comprehensive pharmaceutical supplier contracts covering generic and OTC products distributed across multiple state and local health facilities. Issuing bodies are obtaining these products through competitive bidding processes (IFBs), RFIs to assess vendor capacity for direct-to-manufacturer programs, and multistate cooperative RFPs designed to establish term contracts with multiple awards.

Recent activity spans Florida, Texas, and Minnesota, with particular concentration in multistate cooperative purchasing frameworks. Seminole County, Florida issued IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, an IFB with a response deadline of July 26, 2023 (note: this date appears to be a data error in the source, as it predates the posting). The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling early-stage procurement planning for direct contracting outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with March 26, 2026 proposal deadline, serving participating state and local facilities including Oregon and requiring distribution through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson).